Evidence map›Paper›PMID 39996871›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Comparing Perspectives on Traditional and Complementary Medicine Use in Oncology: Insights from Healthcare Professionals and Oncology Patients in Western Mexico.

Gustavo A Hernandez-Fuentes, Juan de D Gómez-Bueno, Verónica M Pérez-Santos, Imri J Valle-Capitaine, Paula M Villaseñor-Gonzalez, Cristopher J Hernández-Zamorano, César G Silva-Vázquez, Miriam de la Cruz-Ruiz, Janet Diaz-Martinez, Idalia Garza-Veloz and 5 more

Abstract readComparative Study
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. In Vitro Evaluation ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Exploring the Anticancer Activity ofLife (Basel, Switzerland) · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gustavo A Hernandez-FuentesDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-4685-3095
Juan de D Gómez-BuenoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Verónica M Pérez-SantosDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Imri J Valle-CapitaineDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0009-0006-3304-4933
Paula M Villaseñor-GonzalezDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Cristopher J Hernández-ZamoranoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
César G Silva-VázquezState Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico.
Miriam de la Cruz-RuizOficina de Investigación en Salud, Servicios de Salud Del Instituto Mexicano del Seguro Social Para el Bienestar (IMSS-BIENESTAR), Colima 28085, Mexico.
Janet Diaz-MartinezDepartment of Dietetics & Nutrition, Robert Stempel College of Public Health, & Research Center in Minority Institutions, Florida International University, Miami, FL 33199, USA.ORCID 0000-0003-3295-4768
Idalia Garza-VelozMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0002-6307-1696
Iram P Rodriguez-SanchezMolecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, San Nicolas de los Garza 66455, Mexico.ORCID 0000-0002-5988-4168
Margarita L Martinez-FierroMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-1478-9068
José Guzmán-EsquivelClinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.ORCID 0000-0002-6727-0051
Fabian Rojas-LariosDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-1744-9173
Ivan Delgado-EncisoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0001-9848-862X

Funding

National Council of Humanities, Sciences and Technologies (CONAHCYT, Mexico) PRONAII-2024-117
6 · The paper itself

Abstract

Traditional and complementary medicine (T&CM) plays a significant role in healthcare practices among healthcare professionals and oncology patients in Mexico, reflecting its cultural importance. This study aimed to analyze the prevalence, frequency, and factors associated with T&CM use in these two groups, highlighting the differences in practices and perceptions. A total of 382 individuals participated, including 152 healthcare professionals and 230 oncology patients. The findings revealed that while T&CM use was similarly prevalent among healthcare professionals (85.7%) and oncology patients (90.8%), frequent use (≥2 times per week) was significantly higher among patients (46.3%) compared to healthcare professionals (19.1%,

Indexed as

Complementary TherapiesHealth PersonnelMedicine, TraditionalNeoplasmsAdultAgedFemaleHumansMaleMexicoMiddle Agedalternative medicinecomplementary therapiescultural practiceshealthcare professionalsoncology patientsrural communitiestraditional medicine

Identifiers

PMID39996871
PMCPMC11854627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.